Tvardi Therapeutics, Inc. ( TVRD) - Stock Earnings
TVRD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
TVRD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -7.3 million USD | — USD |
| 2026Q1 | -6.8 million USD | — USD |
| 2026Q2 | -6.5 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TVRD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -118.5 million USD | 21.0 million USD |
| 2024 | -70.9 million USD | 7.1 million USD |
| 2025 | -18.2 million USD | — USD |
| 2026 Est. | — | — |
TVRD
Price: $0.99
52 week price:
Earnings Per Share: -2.87 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 10.1 million